yahoo_financeOriginal article
Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis
Data ReadoutpositiveAlixorextonPositive
AI Analysis
Summary
Alkermes announced that Alixorexton demonstrated sustained improvement in wakefulness in adults with narcolepsy types 1 and 2 in a long-term extension study interim analysis.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
Sustained improvement in wakefulness demonstrated in long-term extension study interim analysis
Importance:6/10
Sentiment:
0.70
narcolepsyclinical_datalong-term_extension_studywakefulness
Related Companies
Read the original article
Published by yahoo_finance on July 13, 2026 11:00 AM